Latest filing published 01 Apr 2026 for Oncology Institute, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Daniel Virnich: trading record in brief
Daniel Virnich, listed as chief executive, appears in our data through filings on Starling Oncology, Inc. shares, published by SEC (Form 4). Between 12 November 2021 and 27 March 2026, the trades on record add up to 26 filings.
In open-market terms, that means 1 purchase worth €22k on one side and 1 sale worth €7,402 on the other. Netting one side against the other leaves €14k of net buying. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 10 share grants and 2 option exercises.
On 1 April 2026 came the latest disclosure, a share grant in Starling Oncology, Inc. The last insider purchase was made public on 28 March 2025, 591 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Daniel Virnich
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 670,608 shares0Common StockSEC:0001079973-26-000439:0
- 98,534 shares@ US$3.0750.0% of flowCommon StockSEC:0001079973-26-000439:1
- 11,834 shares@ US$3.596.6% of flowCommon StockSEC:0001079973-26-000332:0
- 6,464 shares0Common StockSEC:0001079973-25-001809:0
- 6,211 shares0Common StockSEC:0001079973-25-001765:0
- 20,388 shares@ US$2.67518.3% of flowCommon stockSEC:0001628280-25-027210:0
- 1,083,334 shares0Common stockSEC:0001799191-25-000017:0
- 22,640 shares@ US$1.04178.3% of flowCommon StockSEC:0001079973-25-000529:0Canonical exit: 24 Jun 2025 (T+90)
- 10,261 shares@ US$0.8893.2% of flowCommon stockSEC:0001799191-25-000008:0
- 4,750 shares@ US$0.1360.2% of flowCommon stockSEC:0001799191-24-000043:0
- 78,094 shares0Common stockSEC:0001799191-24-000033:0
- 11,173 shares@ US$0.59722.3% of flowCommon StockSEC:0001799191-24-000011:0
- 4,322 shares@ US$2.1933.3% of flowCommon stockSEC:0001628280-23-039911:0
- 4,604 shares@ US$2.3853.9% of flowCommon stockSEC:0001628280-23-039300:0
- 114,944 shares0Common stockSEC:0001628280-23-008830:0
- 175,000 shares@ US$0.8654.8% of flowCommon StockSEC:0001799191-22-000056:0
- 3,767 shares@ US$2.02782.8% of flowCommon StockSEC:0001799191-22-000054:0
- 40,101 shares0Common StockSEC:0001799191-22-000044:0
- 3,767 shares@ US$2.02782.8% of flowCommon StockSEC:0001799191-22-000016:0
- 42,015 shares0Common stockSEC:0001628280-22-007098:0
- 78,094 shares0Common StockSEC:0001104659-21-140221:0
21 of 21 declarations
